MX2008002066A - Neuva forma cristalina de perindopril-erbumina. - Google Patents
Neuva forma cristalina de perindopril-erbumina.Info
- Publication number
- MX2008002066A MX2008002066A MX2008002066A MX2008002066A MX2008002066A MX 2008002066 A MX2008002066 A MX 2008002066A MX 2008002066 A MX2008002066 A MX 2008002066A MX 2008002066 A MX2008002066 A MX 2008002066A MX 2008002066 A MX2008002066 A MX 2008002066A
- Authority
- MX
- Mexico
- Prior art keywords
- crystalline form
- new crystalline
- perindopril erbumine
- perindopril
- erbumine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invencion se refiere a una nueva forma cristalina del inhibidor de la enzima convertidora de angiotensina de perindopril, y a procesos para su preparacion.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200500231 | 2005-08-12 | ||
PCT/EP2006/007923 WO2007020009A1 (en) | 2005-08-12 | 2006-08-10 | New crystalline form of perindopril erbumine |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2008002066A true MX2008002066A (es) | 2008-04-16 |
Family
ID=37478710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2008002066A MX2008002066A (es) | 2005-08-12 | 2006-08-10 | Neuva forma cristalina de perindopril-erbumina. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20090099370A1 (es) |
EP (1) | EP1942886A1 (es) |
JP (1) | JP2009505970A (es) |
CN (1) | CN101227902A (es) |
AU (1) | AU2006281681A1 (es) |
CA (1) | CA2618516A1 (es) |
EA (1) | EA200800411A1 (es) |
MX (1) | MX2008002066A (es) |
WO (1) | WO2007020009A1 (es) |
ZA (1) | ZA200800432B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2008002064A (es) * | 2005-08-12 | 2008-04-17 | Lek Pharmaceuticals | Un proceso para la preparacion de perindopril-erbumina. |
AU2013201812B2 (en) * | 2007-06-27 | 2015-04-02 | Les Laboratoires Servier | Salts of perindopril |
SI22543A (sl) * | 2007-06-27 | 2008-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nove soli perindoprila |
PT105315B (pt) | 2010-09-29 | 2013-01-16 | Inst Superior Tecnico | Uma nova forma cristalina hidratada de erbumina de perindopril, métodos para a sua preparação e sua utilização em preparações farmacêuticas |
FR2985511B1 (fr) * | 2012-01-05 | 2014-01-03 | Servier Lab | Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
WO2016178591A2 (en) | 2015-05-05 | 2016-11-10 | Gene Predit, Sa | Genetic markers and treatment of male obesity |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2811319B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
FR2811320B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
FR2811318B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
GB2395195A (en) * | 2002-11-18 | 2004-05-19 | Cipla Ltd | Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors |
BRPI0411966A (pt) * | 2003-06-24 | 2006-08-29 | Servier Lab | formas cristalinas de perindopril erbumina |
ATE452124T1 (de) * | 2003-10-21 | 2010-01-15 | Servier Lab | Verfahren zur herstellung kristallinem perindopril erbumin |
EP1861367B1 (en) * | 2005-03-14 | 2009-07-15 | Les Laboratoires Servier | An improved process for the purification of perindopril |
EP1910287B1 (en) * | 2005-07-25 | 2012-03-14 | LEK Pharmaceuticals d.d. | Process for the preparation of crystalline perindopril |
-
2006
- 2006-08-10 AU AU2006281681A patent/AU2006281681A1/en not_active Abandoned
- 2006-08-10 EA EA200800411A patent/EA200800411A1/ru unknown
- 2006-08-10 CA CA002618516A patent/CA2618516A1/en not_active Abandoned
- 2006-08-10 CN CNA2006800267919A patent/CN101227902A/zh active Pending
- 2006-08-10 US US11/990,351 patent/US20090099370A1/en not_active Abandoned
- 2006-08-10 MX MX2008002066A patent/MX2008002066A/es not_active Application Discontinuation
- 2006-08-10 JP JP2008525485A patent/JP2009505970A/ja not_active Withdrawn
- 2006-08-10 WO PCT/EP2006/007923 patent/WO2007020009A1/en active Application Filing
- 2006-08-10 EP EP06776744A patent/EP1942886A1/en not_active Withdrawn
-
2008
- 2008-01-15 ZA ZA200800432A patent/ZA200800432B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2007020009A1 (en) | 2007-02-22 |
EA200800411A1 (ru) | 2008-08-29 |
AU2006281681A1 (en) | 2007-02-22 |
JP2009505970A (ja) | 2009-02-12 |
EP1942886A1 (en) | 2008-07-16 |
CA2618516A1 (en) | 2007-02-22 |
CN101227902A (zh) | 2008-07-23 |
ZA200800432B (en) | 2008-12-31 |
US20090099370A1 (en) | 2009-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200716525A (en) | Process for preparation of sulfamide derivatives | |
MX2010006736A (es) | Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos. | |
NZ592897A (en) | Crystals of laquinimod sodium, and process for the manufacture thereof | |
MX2007005221A (es) | Formas cristalinas de ascomicina y preparacion de ellas. | |
MY148253A (en) | Azaadamantane derivatives and methods of use | |
EP2194043A3 (en) | Processes and intermediates | |
GEP20104974B (en) | Carbonylamino pyrrolopyrazoles, protent kinase inhibitors | |
PL1682530T3 (pl) | Podstawione pirolo-indole jako inhibitory PAI-1 | |
MX2009003834A (es) | Derivados de pirrolidina como inhibidores de iap. | |
EA200500203A1 (ru) | Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат | |
IL187453A0 (en) | The preparation and uses of compounds as aspartyl protease inhibitors | |
MX2008013196A (es) | 5-amido-2-carboxiamida-indoles. | |
NO20076371L (no) | Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner | |
TW200720232A (en) | Crystalline solid forms of tigecycline and methods of preparing same | |
NO20065046L (no) | Krystallinsk polymorf av bazedoksifenacetat | |
WO2006047528A3 (en) | Pyrazolobenzamides and derivatives as factor xa inhibitors | |
RS70904A (en) | Process for preparing indolinone derivatives | |
WO2006069719A3 (en) | Lyophilization of virosomes | |
MX2008002066A (es) | Neuva forma cristalina de perindopril-erbumina. | |
TW200800986A (en) | Tetrahydroquinolines, synthesis thereof, and intermediates thereto | |
NO20060535L (no) | Aztreonam-L-lysin og fremgangsmater for fremstilling av dette | |
TW200738713A (en) | Diazepinoquinolines, synthesis thereof, and intermediates thereto | |
TW200621703A (en) | Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
WO2007022321A3 (en) | Substituted indoles and use thereof | |
TW200621744A (en) | Mercaptoamides as histone deacetylase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |